GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CG Oncology Inc (NAS:CGON) » Definitions » Change In Other Working Capital

CG Oncology (CG Oncology) Change In Other Working Capital : $-0.03 Mil (TTM As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is CG Oncology Change In Other Working Capital?

CG Oncology's Change In Other Working Capital for the quarter that ended in Mar. 2024 was $-0.03 Mil. It means CG Oncology's Other Working Capital declined by $0.03 Mil from Dec. 2023 to Mar. 2024 .

CG Oncology's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was $0.01 Mil. It means CG Oncology's Other Working Capital increased by $0.01 Mil from Dec. 2022 to Dec. 2023 .

CG Oncology Change In Other Working Capital Historical Data

The historical data trend for CG Oncology's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CG Oncology Change In Other Working Capital Chart

CG Oncology Annual Data
Trend Dec21 Dec22 Dec23
Change In Other Working Capital
-0.09 0.05 0.01

CG Oncology Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Change In Other Working Capital Get a 7-Day Free Trial - - - - -0.03

CG Oncology Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CG Oncology Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of CG Oncology's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

CG Oncology (CG Oncology) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CG Oncology Inc (NAS:CGON) » Definitions » Change In Other Working Capital
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
CG Oncology Inc is a clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. Their product candidate cretostimogene, is initially in clinical development for the treatment of patients with high-risk Non-Muscle Invasive Bladder Cancer who are unresponsive to Bacillus Calmette Guerin (BCG) therapy, the current standard-of-care for high-risk NMIBC.

CG Oncology (CG Oncology) Headlines

From GuruFocus

CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024

By Marketwired • 04-24-2024